The independent risks and specific biomarker of breast cancer-related ischemic stroke

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: Results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759–771.
   PubMed Web of Science ®Google Scholar
• Navi BB, Singer S, Merkler AE, et al. Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke. Stroke. 2014;45(8):2292–2297.
   PubMed Web of Science ®Google Scholar
• Aarnio K, Joensuu H, Haapaniemi E, et al. Cancer in young adults with ischemic stroke. Stroke. 2015;46(6):1601–1606.
   PubMed Web of Science ®Google Scholar
• Kim SG, Hong JM, Kim HY, et al. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke. 2010;41(4):798–801.
   PubMed Web of Science ®Google Scholar
• Kim JM, Jung KH, Park KH, et al. Clinical manifestation of cancer related stroke: retrospective case-control study. J Neurooncol. 2013;111(3):295–301.
   PubMed Web of Science ®Google Scholar
• Guo YJ, Chang MH, Chen PL, et al. Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study. J Stroke Cerebrovasc Dis. 2014;23(4):e249–254.
   PubMed Web of Science ®Google Scholar
• Nam KW, Kim CK, Kim TJ, et al. D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer. Eur J Neurol. 2017;24(1):205–211.
   PubMed Web of Science ®Google Scholar
• Gon Y, Sakaguchi M, Takasugi J, et al. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke. Eur J Neurol. 2017;24(3):503–508.
   PubMed Web of Science ®Google Scholar
• Kono T, Ohtsuki T, Hosomi N, et al. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer. Geriatr Gerontol Int. 2012;12(3):468–474.
   PubMed Web of Science ®Google Scholar
• Panova-Noeva M, Schulz A, Arnold N, et al. Coagulation and inflammation in long-term cancer survivors: results from the adult population. J Thromb Haemost. 2018;16(4):699–708.
   PubMed Web of Science ®Google Scholar
• Kim K, Lee JH. Risk factors and biomarkers of ischemic stroke in cancer patients. J Stroke. 2014;16(2):91–96.
   PubMed Web of Science ®Google Scholar
• Fracassi F, Niccoli G, Vetrugno V, et al. Optical coherence tomography and C-reactive protein in risk stratification of acute coronary syndromes. Int J Cardiol. 2019;286:7–12.
   PubMed Web of Science ®Google Scholar
• Tsai YC, Tsai HJ, Lee CS, Chiu YW, et al. The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease. PLoS One. 2018;13(8):e0202733.
   PubMed Web of Science ®Google Scholar
• Ruiz-Tovar J, Mñnoz JL, Gonzalez J, et al. C-reactive protein, fibrinogen, and procalcitonin levels as early markers of staple line leak after laparoscopic sleeve gastrectomy in morbidly obese patients within an enhanced recovery after surgery (ERAS) program. Surg Endosc. 2017;31(12):5283–5288.
   PubMed Web of Science ®Google Scholar
• Kassubek R, Bullinger L, Kassubek J, et al. Identifying ischemic stroke associated with cancer: a multiple model derived from a case-control analysis. J Neurol. 2017;264(4):781–791.
   PubMed Web of Science ®Google Scholar
• Selvik HA, Bjerkreim AT, Thomassen L, et al. When to screen ischaemic stroke patients for cancer. Cerebrovasc Dis. 2018;45(1-2):42–47.
   PubMed Web of Science ®Google Scholar
• Zöller B, Ji J, Sundquist J, et al. Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48(12):1875–1883.
   PubMed Web of Science ®Google Scholar
• Jauch EC, Saver JL, Adams HP, Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.
   PubMed Web of Science ®Google Scholar
• Adams HJ, Bendixen B, Kappelle L, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41.
   PubMed Web of Science ®Google Scholar
• Navi BB, Reiner AS, Kamel H, et al. Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol. 2017;70(8):926–938.
   PubMed Web of Science ®Google Scholar
• Detremerie C, Timmermans F, De Pauw M, et al. Stroke due to non-bacterial thrombotic endocarditis as initial presentation of breast invasive ductal carcinoma. Acta Clin Belg. 2017;72(4):268–273.
   PubMed Web of Science ®Google Scholar
• Arvold ND, Hsu L, Chen WY, et al. Marantic endocarditis with cardioembolic strokes mimicking leptomeningeal metastases in breast cancer. J Clin Oncol. 2011;29(29):e743–e746.
   PubMed Web of Science ®Google Scholar
• Lai SW, Lin CL, Liao KF. Tamoxifen use correlates with increased risk of the first episode of ischemic cerebrovascular disease in older women with breast cancer: a case-control study in Taiwan. Front Pharmacol. 2017;8:742.
   PubMed Web of Science ®Google Scholar
• Rosell J, Nordenskjöld B, Bengtsson NO, et al. Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial. Br J Cancer. 2011;104(6):899–902.
   PubMed Web of Science ®Google Scholar
• Ligibel JA, James O’Malley A, Fisher M, et al. Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients. Breast Cancer Res Treat. 2012;131(2):589–597.
   PubMed Web of Science ®Google Scholar
• Geiger AM, Fischberg GM, Chen W, et al. Stroke risk and tamoxifen therapy for breast cancer. J Natl Cancer Inst. 2004;96(20):1528–1536.
   PubMedGoogle Scholar
• Ito S, Ueda A, Murate K, et al. Differentiation of cancer from atrial fibrillation in patients with acute multifocal stroke. J Neurol Sci. 2016;368:344–348.
   PubMed Web of Science ®Google Scholar
• Seok JM, Kim SG, Kim JW, et al. Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol. 2010;68(2):213–219.
   PubMed Web of Science ®Google Scholar
• Ferroni P, Riondino S, Formica V, et al. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio. Int J Cancer. 2015;136(5):1234–1240.
   PubMed Web of Science ®Google Scholar
• Krenn-Pilko S, Langsenlehner U, Thurner EM, et al. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer. 2014;110(10):2524–2530.
   PubMed Web of Science ®Google Scholar
• Alexandrakis MG, Passam FH, Moschandrea IA, et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol. 2003;26(2):135–140.
   PubMed Web of Science ®Google Scholar
• Jovin TG, Boosupalli V, Zivkovic SA, et al. High titers of CA-125 may be associated with recurrent ischemic strokes in patients with cancer. Neurology. 2005;64(11):1944–1945.
   PubMed Web of Science ®Google Scholar
• Shao B, Wahrenbrock MG, Yao L, et al. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood. 2011;118(15):4015–4023.
   PubMed Web of Science ®Google Scholar
• Choi JW, Moon BI, Lee JW, et al. Use of CA153 for screening breast cancer: an antibodylectin sandwich assay for detecting glycosylation of CA153 in sera. Oncol Rep. 2018;40(1):145–154.
   PubMed Web of Science ®Google Scholar
• Arboix A, Cartanya A, Lowak M, et al. Gender differences and woman-specific trends in acute stroke: results from a hospital-based registry (1986-2009). Clin Neurol Neurosurg. 2014;127:19–24.
   PubMed Web of Science ®Google Scholar
• Arboix A, Blanco-Rojas L, Martí-Vilalta JL. Advancements in understanding the mechanisms of symptomatic lacunar ischemic stroke: translation of knowledge to prevention strategies. Expert Rev Neurother. 2014;14(3):261–276.
   PubMed Web of Science ®Google Scholar